• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Neuraly Announces Results from Phase 2 Trial of NLY01 in Parkinson`s Disease

    BUSINESSWIRE

    Neuraly points to younger patients as Parkinson`s bet fails

    FIERCE BIOTECH

    Neuraly Completes Enrollment in PII Trial of NLY01 in Parkinson’s Disease

    BUSINESSWIRE

    Neuraly Announces Publication in Acta Neuropathologica of Preclinical

    BUSINESSWIRE

    Neuraly Announces Strategic Sponsored Research Agreement with the University

    BUSINESSWIRE

    Neuraly Receives FDA Clearance of INDA to Initiate Phase 2B Trial of NLY01

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.